What happened
Getting vaccinated against shingles appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia, according to a study published Wednesday in the journal Nature. The study, based on the health records of 280,000 people in Wales, found that those who received an older live-virus vaccine, Zostavax, were 20% less likely to develop dementia within seven years than those not vaccinated.
Who said what
Previous research suggested that "shingles vaccinations might reduce dementia risk," including a 2024 study that found even greater protection from the newer vaccine Shingrix, The New York Times said. But the latest study overcame limitations in earlier observational data by taking advantage of a "natural experiment" in Wales, where health officials allowed 79-year-olds to get vaccinated but not 80-year-olds, effectively creating a randomized trial among two groups born weeks apart.
A 20% dementia reduction from the shingles vaccine would be "quite important," especially as "we don’t really have much else at the moment that slows down the onset of dementia," Oxford researcher Dr. Paul Harrison, who wasn't involved in this study, told the Times. People should get vaccinated regardless, Dr. Aarati Didwania of Northwestern University said to NBC News. "Shingles is a terrible, painful and debilitating condition that can lead to horrendous long-term pain."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
Further research is needed to understand why viruses like shingles and other members of the herpes family appear to boost dementia odds, why the shingles vaccine offers protection and the efficacy of Shingrix.
-
Scientists have developed a broad-spectrum snake bite antivenomUnder the radar It works on some of the most dangerous species
-
How medical imposters are ruining health studiesUnder the Radar Automated bots and ‘lying’ individuals ‘threaten’ patient safety and integrity of research
-
Doctors sound the alarm about insurance company ‘downcoding’The Explainer ‘It’s blatantly disrespectful,’ one doctor said
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
‘Nightmare bacteria’ are rapidly spreadingUnder the radar The infections are largely resistant to antibiotics
-
Private equity firms might be causing more deaths in hospital ERsThe Explainer Deaths in ERs purchased by private equity firms rose 13%
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
